An extract from alfalfa meal, operationally defined as alfalfa saponins, was
incorporated into the food of female cynomolgus macaques (Macaca fascicularis). Monkeys
received diets with and without added cholesterol. No signs of toxicity were detected
from records of survival and body weight, from multiple hematologic and serum parameters,
or from macroscopic and microscopic examination of various organs and tissues.
Since alfalfa saponins lower plasma cholesterol levels and decrease atherogenesis, they may
be useful for treating patients with atherosclerosis associated with a disturbed cholesterol
metabolism.